Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
20 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/promontory-therapeutics-announces-successful-end-of-phase-2-meeting-with-us-fda-on-phase-3-registrational-study-design-for-pt-112-in-patients-with-metastatic-castration-resistant-prostate-cancer-302459819.html
08 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/promontory-therapeutics-completes-enrollment-of-phase-2-trial-of-pt-112-in-late-line-patients-with-metastatic-castration-resistant-prostate-cancer-302083644.html
26 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/promontory-therapeutics-to-present-data-on-pt-112-mechanism-of-action-at-the-society-for-immunotherapy-of-cancers-38th-annual-meeting-301968314.html
14 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/promontory-therapeutics-presents-data-on-the-molecular-effects-of-pt-112-at-the-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics-301956747.html
05 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/promontory-therapeutics-announces-early-phase-2-clinical-trial-data-from-the-national-cancer-institute-demonstrating-pt-112s-immune-activation-in-thymic-epithelial-tumors-301947973.html
04 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/promontory-therapeutics-to-present-molecular-effects-of-pt-112-at-the-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics-301946624.html
ABOUT THIS PAGE